Safety and Efficacy of the EndyMed Pro System Using RF Micro-needles Fractional Skin Remodeling

Inclusion Criteria: * Healthy patients age 35-60 with facial condition as required by the treatment. * Subjects with Fitzpatrick elasticity level of 4 and above * Subject able to comprehend and sign informed consent for participation in this study. * Subject must commit to all treatments and follow-up visits. * Subjects must approve the use of their B\&A photos by the doctor and EndyMed Exclusion Criteria: * Subjects with implanted pacemakers, arrhythmias or any other electronic implanted device or severe known heart disorder * Subjects with any implantable metal device in the treatment area. * Subjects on any medication that would affect the characteristic of the skin (medical or hormonal), such as "Accutane", within the past 3 months. * Subjects that have had any other invasive or noninvasive method of skin therapy hair removal, filers or Botox, performed in the past 3 months (in the treated area). * Subjects who are scheduled or planned for any other invasive or noninvasive method of skin therapy in the treatment area at the period of the study. * Subjects who have any form of suspicious lesion on the treatment area. * Subjects with hypertrophic scarring, keloids, abnormal wound healing, as well as very dry and fragile skin. * Pregnant or lactating Subjects. * Subjects with Epilepsy or severe migraines. * Subjects with permanent makeup/ tattoo/ body piercing (in the treated area). * Subjects with any Infection / abscess / pains in treatment target area. * History of any kind of cancer * Any active condition in the treatment area, such as sores, psoriasis, eczema, and rash. * Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications. * Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regime. * Any surgical procedure in the treatment area within the last 3 months or before complete healing. * Excessively tanned skin from sun, tanning beds or tanning creams within the last two weeks. * Treating over the thyroid, breast or any other sensitive area. * Subjects who suffer from autoimmune disorders or diabetes. * Subjects using blood thinning medications. * Subjects with clotting disorders. * Subjects on drugs or psychologically determined unsuitable for the study. * Subject is suffering extreme general weakness. * Subject objects to the study protocol or unwilling to sign a consent form. Concurrent participation in any other clinical study. * Any other condition that exclude the patient from the evaluation according to the physician judgment.